Linmei Li

Guangdong Provincial Key Laboratory Of Allergy & Clinical Immunology, The State Key Laboratory Of Respiratory Disease, 250 Changgang Road East
Guangzhou, 510260, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Stabilization of MHCII on dendritic cells via AhR-mediated blockade of proteasomal degradation drives Th17 responses to exogenous antigens.

Stabilization of MHCII on dendritic cells via AhR-mediated blockade of proteasomal degradation drives Th17 responses to exogenous antigens.

Journal: International immunopharmacology

Published: March 24, 2026

Skin inflammation and lipid disorder induced by topical application of Mal f 1.

Skin inflammation and lipid disorder induced by topical application of Mal f 1.

Journal: International immunopharmacology

Published: December 26, 2024

Small airway impairment and bronchial hyperreactivity in patients with house dust mites-allergic rhinitis.

Small airway impairment and bronchial hyperreactivity in patients with house dust mites-allergic rhinitis.

Journal: Asia Pacific allergy

Published: December 01, 2024

Contribution of Pseudomonas aeruginosa - mediated club cell necroptosis to the bias of type 17 inflammation and steroid insensitivity in asthma.

Contribution of Pseudomonas aeruginosa - mediated club cell necroptosis to the bias of type 17 inflammation and steroid insensitivity in asthma.

Journal: Journal of advanced research

Published: June 27, 2024

Pseudomonas aeruginosa exotoxin A as a novel allergen induced Non-TH2 inflammation in a murine model of steroid-insensitive asthma.

Pseudomonas aeruginosa exotoxin A as a novel allergen induced Non-TH2 inflammation in a murine model of steroid-insensitive asthma.

Journal: Heliyon

Published: April 16, 2024

Ferroptotic alveolar epithelial type II cells drive TH2 and TH17 mixed asthma triggered by birch pollen allergen Bet v 1.

Ferroptotic alveolar epithelial type II cells drive TH2 and TH17 mixed asthma triggered by birch pollen allergen Bet v 1.

Journal: Cell death discovery

Published: October 26, 2023

Cell-in-cell promotes lung cancer malignancy by enhancing glucose metabolism through mitochondria transfer.

Cell-in-cell promotes lung cancer malignancy by enhancing glucose metabolism through mitochondria transfer.

Journal: Experimental cell research

Published: December 15, 2022

FcRn-targeting and ROS-responsive Fedratinib-incorporated nanoparticles alleviate asthma by inducing eosinophil apoptosis.

FcRn-targeting and ROS-responsive Fedratinib-incorporated nanoparticles alleviate asthma by inducing eosinophil apoptosis.

Journal: Allergy

Published: May 23, 2022

Heterotypic cell-in-cell structures in colon cancer can be regulated by IL-6 and lead to tumor immune escape.

Heterotypic cell-in-cell structures in colon cancer can be regulated by IL-6 and lead to tumor immune escape.

Journal: Experimental cell research

Published: December 20, 2018

Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment.

Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment.

Journal: Toxins

Published: January 05, 2016

Cell-in-Cell Death Is Not Restricted by Caspase-3 Deficiency in MCF-7 Cells.

Cell-in-Cell Death Is Not Restricted by Caspase-3 Deficiency in MCF-7 Cells.

Journal: Journal of breast cancer

Published: December 15, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026